During the past decade, Consultation office conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Consultation office" #1 collaborator was "Axial Biotech, Inc" with 1 trials as a collaborator and "Iris Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Consultation office" are "Demodex Blepharitis" (1 trials), "Meibomian Gland Dysfunction" (1 trials), "Ocular Surface Disease" (1 trials) and "Palpebral Pathologies" (1 trials). Many other conditions were trialed in "Consultation office" in a lesser frequency.

Most popular intervention types in "Consultation office" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blephademodex" (1 trials). Other intervention names were less common.

The vast majority of trials in "Consultation office" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Consultation office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Consultation office, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Consultation office, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".